National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings, 28514 [07-2493]
Download as PDF
<![CDATA[
28514
Federal Register / Vol. 72, No. 97 / Monday, May 21, 2007 / Notices
Office, National Institute on Aging, Gateway
Building, 7201 Wisconsin Avenue/Suite
2C212, Bethesda, MD 20892, (301) 496–7705,
hsul@exmur.nia.nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel, AD Clinical
Trials.
Date: June 22, 2007.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
2C212, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Ramesh Vemuri, PhD,
Scientific Review Office, National Institute
on Aging, National Institutes of Health, 7201
Wisconsin Avenue, Suite 2C–212, Bethesda,
MD 20892, 301–402–7700, rv23r@nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel, EXERCISE
AND DISABILITY.
Date: June 25, 2007.
Time: 12 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
2C212, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Ramesh Vemuri, PhD,
Scientific Review Office, National Institute
on Aging, National Institutes of Health, 7201
Wisconsin Avenue, Suite 2C–212, Bethesda,
MD 20892, 301–402–7700, rv23r@nih.gov
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
pwalker on PROD1PC71 with NOTICES
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
15:57 May 18, 2007
Jkt 211001
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel, NSDK Member Conflict
SEP.
Date: June 29, 2007.
Time: 8 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Watergate Hotel, 2650 Virginia
Avenue, NW., Washington, DC 20037.
Contact Person: Alan L. Willard, PhD,
Scientific Review Administrator, Scientific
Review Branch NINDS/NIH/DHHS,
Neuroscience Center, 6001 Executive Blvd.,
Suite 3208, MSC 9529, Bethesda, MD 20892–
9529, (301) 496–5390,
willarda@ninds.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: May 14, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–2492 Filed 5–18–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
Dated: May 14, 2007.
Jennifer Spaeth
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–2490 Filed 5–18–07; 8:45 am]
VerDate Aug<31>2005
would constitute a clearly unwarranted
invasion of personal privacy.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal property.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, Efficacy of Setraline
as a Treatment for Cholestatic Pruritus.
Date: June 29, 2007.
Time: 2:30 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
Contact Person: Paul A. Rushing, PhD,
Scientific Review Administrator, Review
Branch, DEA, NIDDK, National Institutes of
Health, Room 747, 6707 Democracy
Boulevard, Bethesda, MD 20892–5452, (301)–
594–8895, rushingp@extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, The NIDDK
Digestive Disease Development Centers
Review.
Date: July 13, 2007.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Marriott Bethesda North Hotel &
Conference Center, 5701 Marinelli Road,
North Bethesda, MD 20852.
Contact Person: Xiaodu Guo, MD, PhD,
Scientific Review Administrator, Review
Branch, DEA, NIDDK, National Institutes of
Health, Room 910, 6707 Democracy
Boulevard, Bethesda, MD 20892–5452, (301)–
594–4719, guox@extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, CRISP and AASK
Ancillary Studies.
Date: July 13, 2007.
Time: 2 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20852, (Telephone
Conference Call).
Contact Person: Barbara A. Woynarowska,
PhD, Scientific Review Administrator,
Review Branch, DEA, NIDDK, National
Institutes of Health, Room 754, 6707
Democracy Boulevard, Bethesda, MD 20892–
5452, (301)–402–7172,
woynarowskab@niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: May 14, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–2493 Filed 5–18–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Child Health and
Human Development; Amended Notice
of Meeting
Notice is hereby given of a change in
the meeting of the Developmental
Biology Subcommittee, June 7, 2007,
8:30 a.m. to June 7, 2007, 5 p.m., Hotel
Washington, Pennsylvania Avenue at
15th Street, NW., Washington, DC
E:\FR\FM\21MYN1.SGM
21MYN1
]]>Agencies
[Federal Register Volume 72, Number 97 (Monday, May 21, 2007)]
[Notices]
[Page 28514]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-2493]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal property.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel, Efficacy of Setraline as
a Treatment for Cholestatic Pruritus.
Date: June 29, 2007.
Time: 2:30 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference
Call).
Contact Person: Paul A. Rushing, PhD, Scientific Review
Administrator, Review Branch, DEA, NIDDK, National Institutes of
Health, Room 747, 6707 Democracy Boulevard, Bethesda, MD 20892-5452,
(301)-594-8895, rushingp@extra.niddk.nih.gov.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel, The NIDDK Digestive
Disease Development Centers Review.
Date: July 13, 2007.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Marriott Bethesda North Hotel & Conference Center, 5701
Marinelli Road, North Bethesda, MD 20852.
Contact Person: Xiaodu Guo, MD, PhD, Scientific Review
Administrator, Review Branch, DEA, NIDDK, National Institutes of
Health, Room 910, 6707 Democracy Boulevard, Bethesda, MD 20892-5452,
(301)-594-4719, guox@extra.niddk.nih.gov.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel, CRISP and AASK Ancillary
Studies.
Date: July 13, 2007.
Time: 2 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20852, (Telephone Conference
Call).
Contact Person: Barbara A. Woynarowska, PhD, Scientific Review
Administrator, Review Branch, DEA, NIDDK, National Institutes of
Health, Room 754, 6707 Democracy Boulevard, Bethesda, MD 20892-5452,
(301)-402-7172, woynarowskab@niddk.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
Dated: May 14, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-2493 Filed 5-18-07; 8:45 am]
BILLING CODE 4140-01-M
